Prof. Dr. Rainer Fietkau

Lehrstuhl für Strahlentherapie

TTFIELDS IN ROUTINE CLINICAL CARE OF NEWLY DIAGNOSED GBM PATIENTS IN GERMANY - FIRST REPORT ON THE FULLY ENROLLED TIGER STUDY POPULATION (2020) Baehr O, Tabatabai G, Fietkau R, Goldbrunner R, Glas M Conference contribution Classification of primary cerebral lymphoma and glioblastoma featuring dynamic susceptibility contrast and apparent diffusion coefficient (2020) Eisenhut F, Schmidt M, Putz F, Lettmaier S, Fröhlich K, Arinrad S, Coras R, et al. Journal article Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells (2020) Sun R, Sundahl N, Hecht M, Putz F, Lancia A, Rouyar A, Milic M, et al. Journal article High stroma T-cell infiltration is associated with better survival in stage pT1 bladder cancer (2020) Hülsen S, Lippolis E, Ferrazzi F, Otto W, Distel L, Fietkau R, Denzinger S, et al. Journal article Tumour-infiltrating inflammatory cells in early breast cancer: An underrated prognostic and predictive factor? (2020) Schnellhardt S, Erber R, Büttner-Herold M, Rosahl MC, Ott O, Strnad V, Beckmann M, et al. Journal article Prospective evaluation of the prognostic value of immune-related adverse events in patients with non-melanoma solid tumour treated with PD-1/PD-L1 inhibitors alone and in combination with radiotherapy (2020) Schweizer C, Schubert P, Rutzner S, Eckstein M, Haderlein M, Lettmaier S, Semrau S, et al. Journal article Prospective Evaluation of All-lesion Versus Single-lesion Radiotherapy in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors (2020) Schubert P, Rutzner S, Eckstein M, Frey B, Schweizer C, Haderlein M, Lettmaier S, et al. Journal article Targeted Natural Killer Cell-Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical Trial (2020) Multhoff G, Seier S, Stangl S, Sievert W, Shevtsov M, Werner C, Pockley AG, et al. Journal article Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8 (2020) Hecht M, Gostian AO, Eckstein M, Rutzner S, von der Grün J, Illmer T, Hautmann MG, et al. Journal article FSRT vs. SRS in Brain Metastases—Differences in Local Control and Radiation Necrosis—A Volumetric Study (2020) Putz F, Weissmann T, Oft D, Schmidt M, Roesch J, Siavooshhaghighi H, Filimonova I, et al. Journal article